Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
Highest Quality | For Research Use Only

Triptorelin

Buy Triptorelin Peptide France

Triptorelin, a decapeptide and synthetic analogue of gonadotropin-releasing hormone (GnRH), plays a crucial role in regulating sex hormone release. Widely used in medicine, it has shown therapeutic efficacy in hormone-responsive cancers like prostate and breast cancer, endometriosis, and precocious puberty.

Triptorelin acts by binding to GnRH receptors on the anterior pituitary gland. Initially, it stimulates luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release. However, according to research, prolonged administration leads to receptor desensitization and downregulation, causing reduced secretion of LH and FSH. This results in a chemical castration state, which aids in managing hormone-dependent conditions.

Showing all 3 results

Potential Benefits of Triptorelin Peptide

  • GnRH Agonist: Triptorelin is a gonadotropin-releasing hormone (GnRH) agonist. According to research, it acts by desensitizing the pituitary gland, leading to a reduction in the production of sex hormones, which can be beneficial in specific medical conditions [1].
  • Prostate Cancer Treatment: Triptorelin has been extensively used in the management of advanced prostate cancer. Studies indicate it reduces testosterone levels, thereby slowing the progression of the disease [2].
  • Endometriosis Management: In women, triptorelin is used for treating endometriosis. Research suggests it decreases the level of estrogen in the body, which helps in relieving pain and reducing the size of endometrial implants [3].
  • Precocious Puberty: Triptorelin is also used in pediatric endocrinology for the treatment of central precocious puberty. Research indicates it works by delaying the release of certain hormones to delay early puberty [4].
  • Research Potential: Ongoing research investigates the potential use of triptorelin in other diseases like breast cancer and uterine fibroids, expanding its scope within the pharmaceutical field [5].
  • Safety Profile: Most studies show that triptorelin has a favorable safety profile, with hot flushes being the most common adverse effect. However, research suggests long-term use could potentially cause reduced bone mineral density [6].

References

[1] https://pubmed.ncbi.nlm.nih. gov/15082521/

[2] https://pubmed.ncbi.nlm.nih. gov/21788033/

[3] https://pubmed.ncbi.nlm.nih. gov/11978277/

[4] https://pubmed.ncbi.nlm.nih. gov/19332438/

[5] https://pubmed.ncbi.nlm.nih. gov/11208825/

[6] https://pubmed.ncbi.nlm.nih. gov/22733160/

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Peptides website: https://france.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.